Amicus Therapeutics
FOLD
#3312
Rank
A$6.59 B
Marketcap
A$21.01
Share price
0.00%
Change (1 day)
82.49%
Change (1 year)

EPS for Amicus Therapeutics (FOLD)

EPS in 2023 (TTM): A-$0.96

According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$0.16. In 2022 the company made an earnings per share (EPS) of A-$1.19 an increase over its 2021 EPS that were of A-$1.33.

EPS history for Amicus Therapeutics from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$0.96-19.28%
2022A-$1.19-10.87%
2021A-$1.33-14.02%
2020A-$1.55-29.14%
2019A-$2.19-18.82%
2018A-$2.701.64%
2017A-$2.6522%
2016A-$2.1726.05%
2015A-$1.7327.96%
2014A-$1.35-19.13%
2013A-$1.675.5%
2012A-$1.58-15.5%
2011A-$1.87-35.18%
2010A-$2.88610.71%
2009A-$0.41-83.91%
2008A-$2.52-86.15%
2007A-$18.22-85.97%
2006A-$129.8882.72%
2005A-$71.08

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
A$5.91-3,806.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
A$3.42-2,245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.17-2,715.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
A-$0.22 36.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.02899-81.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.55-445.45%๐Ÿ‡บ๐Ÿ‡ธ USA